SCARB1 and glioblastoma: Since HDL NPs can cross the BBB [40,41], the rHDL NPs platform may be an appropriate vehicle to selectively deliver AMN to high SR-B1-expressing GBM tumors while reducing off-target exposure to healthy brain tissue.